Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
General Review Article

Advanced Research in Cellular Pharmacokinetics and its Cutting-edge Technologies

Author(s): Lingjuan Lv, Yuyang You, Yeju Liu and Zhihong Yang*

Volume 28, Issue 37, 2022

Published on: 13 October, 2022

Page: [3095 - 3104] Pages: 10

DOI: 10.2174/1381612828666220907102606

Price: $65

Abstract

Pharmacokinetics (PK), as a significant part of pharmacology, runs through the overall process of the preclinical and clinical research on drugs and plays a significant role in determining the material basis of efficacy and mechanism research. However, due to the limitations of classical PK, cellular PK was put forward and developed rapidly. Many novel and original technologies have been innovatively applied to cellular PK research, thereby providing powerful technical support. As a novel field of PK research, cellular PK expands the research object and enriches the theoretical framework of PK. It provides a new perspective for elucidating the mechanism of drug action and the dynamic process of drug in the body. Furthermore, it provides a scientific basis and guiding significance for the development of new drugs and clinical rational drug use. Cellular PK can explain the dynamic process of certain drugs (e.g., antineoplastic drugs and antibiotics) and the disposition kinetics characteristics in some specific tissues (e.g., brain and tumor) in a clearer and more accurate manner. It is a beneficial supplement and the perfection of traditional PK. In the future, traditional and cellular PKs will complement each other well and improve into an all-around research system in drug developments. Briefly, this paper reviews the conceptual development of cellular PK and key associated technologies, explores its main functions and applications, and looks forward to the important pioneering significance and promising value for the development of PK.

Keywords: Cellular pharmacokinetics, pharmacokinetics, theoretical development, technology, application, research progress

« Previous
[1]
Drews J. Drug discovery: A historical perspective. Science 2000; 287(5460): 1960-4.
[http://dx.doi.org/10.1126/science.287.5460.1960] [PMID: 10720314]
[2]
Larsen AK, Escargueil AE, Skladanowski A. Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Pharmacol Ther 2000; 85(3): 217-29.
[http://dx.doi.org/10.1016/S0163-7258(99)00073-X] [PMID: 10739876]
[3]
Feng L, Wang L, Hu C, Jiang X. Pharmacokinetics, tissue distribution, metabolism, and excretion of ginsenoside Rg1 in rats. Arch Pharm Res 2010; 33(12): 1975-84.
[http://dx.doi.org/10.1007/s12272-010-1213-2] [PMID: 21191763]
[4]
Zha W, Liang G, Xiao J, et al. Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages. PLoS One 2010; 5(2): e9069.
[http://dx.doi.org/10.1371/journal.pone.0009069] [PMID: 20161729]
[5]
Zhou F, Zhang J, Li P, et al. Toward a new age of cellular pharmacokinetics in drug discovery. Drug Metab Rev 2011; 43(3): 335-45.
[http://dx.doi.org/10.3109/03602532.2011.560607] [PMID: 21395404]
[6]
Chu X, Korzekwa K, Elsby R, et al. Intracellular drug concentrations and transporters: Measurement, modeling, and implications for the liver. Clin Pharmacol Ther 2013; 94(1): 126-41.
[http://dx.doi.org/10.1038/clpt.2013.78] [PMID: 23588320]
[7]
Ni P, Zhang J, Liu J, Chen Q, Wang G, Zhou F. Research progress in cellular pharmacokinetics. Prog Pharm Sci 2014; 38(12): 881-5.
[8]
Feng S, Wang G, Zhang J, et al. Combined treatment with apatinib and docetaxel in A549 xenograft mice and its cellular pharmacokinetic basis. Acta Pharmacol Sin 2018; 39(10): 1670-80.
[http://dx.doi.org/10.1038/aps.2018.16] [PMID: 29770798]
[9]
Wang G, Wang Q, Rao T, et al. A robust LC–MS/MS method for the determination of pidotimod in different biological matrixes and its application to in vivo and in vitro pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci 2016; 1023-1024: 36-43.
[http://dx.doi.org/10.1016/j.jchromb.2016.04.047] [PMID: 27179190]
[10]
Schäfer J, Welti L, Seckinger A, Burhenne J, Theile D, Weiss J. Cellular effect and efficacy of carfilzomib depends on cellular net concentration gradient. Cancer Chemother Pharmacol 2017; 80(1): 71-9.
[http://dx.doi.org/10.1007/s00280-017-3335-4] [PMID: 28500557]
[11]
Yanagi S, Sugai T, Noguchi T, et al. Fluorescence-labeled neopeltolide derivatives for subcellular localization imaging. Org Biomol Chem 2019; 17(28): 6771-6.
[http://dx.doi.org/10.1039/C9OB01276A] [PMID: 31259993]
[12]
Yang M, Cao S, Sun X, et al. Self-assembled naphthalimide conjugated porphyrin nanomaterials with D–A structure for PDT/PTT synergistic therapy. Bioconjug Chem 2020; 31(3): 663-72.
[http://dx.doi.org/10.1021/acs.bioconjchem.9b00819] [PMID: 31884782]
[13]
Li Q, Zhou T, Liu C, et al. Mitochondrial membrane potential played crucial roles in the accumulation of berberine in HepG2 cells. Biosci Rep 2019; 39(4): BSR20190477.
[http://dx.doi.org/10.1042/BSR20190477] [PMID: 30944202]
[14]
Türkcan S, Nguyen J, Vilalta M, et al. Single-cell analysis of [18F]fluorodeoxyglucose uptake by droplet radiofluidics. Anal Chem 2015; 87(13): 6667-73.
[http://dx.doi.org/10.1021/acs.analchem.5b00792] [PMID: 26035453]
[15]
Gallina ME, Kim TJ, Shelor M, et al. Toward a droplet-based single-cell radiometric assay. Anal Chem 2017; 89(12): 6472-81.
[http://dx.doi.org/10.1021/acs.analchem.7b00414] [PMID: 28562033]
[16]
Zhang XC, Zang Q, Zhao H, et al. Combination of droplet extraction and pico-ESI-MS allows the identification of metabolites from single cancer cells. Anal Chem 2018; 90(16): 9897-903.
[http://dx.doi.org/10.1021/acs.analchem.8b02098] [PMID: 30040884]
[17]
Zang Q, Sun C, Chu X, et al. Spatially resolved metabolomics combined with multicellular tumor spheroids to discover cancer tissue relevant metabolic signatures. Anal Chim Acta 2021; 1155: 338342.
[http://dx.doi.org/10.1016/j.aca.2021.338342] [PMID: 33766316]
[18]
Sha W. A microfluidic chip imaging system for monitoring cell pharmacokinetics. Henan province 2018.
[19]
Liu Z, Jian Z, Wang Q, et al. Continuously infused microfluidic radioassay system for the characterization of cellular pharmacokinetics. J Nucl Med 2016; 57(10): 1548-55.
[http://dx.doi.org/10.2967/jnumed.115.169151]
[20]
Liu Z, Zhang P, Ji H, et al. A mini-panel PET scanner-based microfluidic radiobioassay system allowing high-throughput imaging of real-time cellular pharmacokinetics. Lab Chip 2020; 20(6): 1110-23.
[http://dx.doi.org/10.1039/C9LC01066A] [PMID: 32043092]
[21]
Zaman RT, Tuerkcan S, Mahmoudi M, et al. Imaging cellular pharmacokinetics of 18F-FDG and 6-NBDG uptake by inflammatory and stem cells. PLoS One 2018; 13(2): e0192662.
[http://dx.doi.org/10.1371/journal.pone.0192662] [PMID: 29462173]
[22]
Lee H, Kim DS, Ha SK, Choi I, Lee JM, Sung JH. A pumpless multi-organ-on-a-chip (MOC) combined with a pharmacokinetic-pharmacodynamic (PK-PD) model. Biotechnol Bioeng 2017; 114(2): 432-43.
[http://dx.doi.org/10.1002/bit.26087] [PMID: 27570096]
[23]
Lee Y, Kim MH, Alves DR, et al. Gut–kidney axis on chip for studying effects of antibiotics on risk of hemolytic uremic syndrome by shiga toxin-producing Escherichia coli. Toxins 2021; 13(11): 775.
[http://dx.doi.org/10.3390/toxins13110775] [PMID: 34822559]
[24]
Jie M. Research on cell co-culture and pharmacokinetic simulation based on microfluidic chip. Thesis, Beijing University of Chemical Technology, Beijing 2017.
[25]
Wang CS, Chang CH, Tzeng TY, Lin AMY, Lo YL. Gene-editing by CRISPR–Cas9 in combination with anthracycline therapy via tumor microenvironment-switchable, EGFR-targeted, and nucleus-directed nanoparticles for head and neck cancer suppression. Nanoscale Horiz 2021; 6(9): 729-43.
[http://dx.doi.org/10.1039/D1NH00254F] [PMID: 34323910]
[26]
Sen M, Al-Amin M, Kicková E, et al. Retinal neuroprotection by controlled release of a VCP inhibitor from self-assembled nanoparticles. J Control Release 2021; 339: 307-20.
[http://dx.doi.org/10.1016/j.jconrel.2021.09.039] [PMID: 34606936]
[27]
Kreuter J. Nanoparticles—a historical perspective. Int J Pharm 2007; 331(1): 1-10.
[http://dx.doi.org/10.1016/j.ijpharm.2006.10.021] [PMID: 17110063]
[28]
Kang JH, Jang WY, Ko YT. The effect of surface charges on the cellular uptake of liposomes investigated by live cell imaging. Pharm Res 2017; 34(4): 704-17.
[http://dx.doi.org/10.1007/s11095-017-2097-3] [PMID: 28078484]
[29]
Lima AC, Reis RL, Ferreira H, Neves NM. Cellular uptake of three different nanoparticles in an inflammatory arthritis scenario versus normal conditions. Mol Pharm 2021; 18(9): 3235-46.
[http://dx.doi.org/10.1021/acs.molpharmaceut.1c00066] [PMID: 34387081]
[30]
Qiu L, Shan X, Long M, et al. Elucidation of cellular uptake and intracellular trafficking of heparosan polysaccharide-based micelles in various cancer cells. Int J Biol Macromol 2019; 130: 755-64.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.02.133] [PMID: 30851320]
[31]
Vamanu E, Ene M, Biță B, Ionescu C, Crăciun L, Sârbu I. in vitro human microbiota response to exposure to silver nanoparticles biosynthesized with mushroom extract. Nutrients 2018; 10(5): 607.
[http://dx.doi.org/10.3390/nu10050607] [PMID: 29757931]
[32]
Gimondi S, Guimarães CF, Vieira SF, et al. Microfluidic mixing system for precise PLGA-PEG nanoparticles size control. Nanomedicine 2022; 40: 102482.
[http://dx.doi.org/10.1016/j.nano.2021.102482] [PMID: 34748958]
[33]
Serpooshan V, Sheibani S, Pushparaj P, et al. Effect of cell sex on uptake of nanoparticles: The overlooked factor at the nanobio interface. ACS Nano 2018; 12(3): 2253-66.
[http://dx.doi.org/10.1021/acsnano.7b06212] [PMID: 29536733]
[34]
Yin S, Chang L, Li T, Wang G, Gu X, Li J. Construction of novel pH-sensitive hybrid micelles for enhanced extracellular stability and rapid intracellular drug release. RSC Adv 2016; 6(107): 105957-68.
[http://dx.doi.org/10.1039/C6RA23050D]
[35]
Lu M, Zhou F, Liu J, et al. Progress in application of three-dimensional cell model in early pharmacokinetic screening of antitumor drugs. Chinese J Clin Pharmacol Therapeut 2017; 22(03): 342-9.
[36]
Li W, Hu X, Yang S, et al. A novel tissue-engineered 3D tumor model for anti-cancer drug discovery. Biofabrication 2018; 11(1): 015004.
[http://dx.doi.org/10.1088/1758-5090/aae270] [PMID: 30229749]
[37]
Eetezadi S, De Souza R, Vythilingam M, Lessa Cataldi R, Allen C. Effects of doxorubicin delivery systems and mild hyperthermia on tissue penetration in 3D cell culture models of ovarian cancer residual disease. Mol Pharm 2015; 12(11): 3973-85.
[http://dx.doi.org/10.1021/acs.molpharmaceut.5b00426] [PMID: 26394060]
[38]
Herrera-Martínez AD, Feelders RA, Van den Dungen R, et al. Effect of the tryptophan hydroxylase inhibitor telotristat on growth and serotonin secretion in 2D and 3D cultured pancreatic neuroendocrine tumor cells. Neuroendocrinology 2020; 110(5): 351-63.
[http://dx.doi.org/10.1159/000502200] [PMID: 31319410]
[39]
Curran S, Vantangoli MM, Boekelheide K, Morgan JR. Architecture of chimeric spheroids controls drug transport. Cancer Microenviron 2015; 8(2): 101-9.
[http://dx.doi.org/10.1007/s12307-015-0171-0] [PMID: 26239082]
[40]
Ling X, Tu J, Wang J, et al. Glutathione-responsive prodrug nanoparticles for effective drug delivery and cancer therapy. ACS Nano 2019; 13(1): 357-70.
[http://dx.doi.org/10.1021/acsnano.8b06400] [PMID: 30485068]
[41]
Liggins RT, Burt HM. Polyether–polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. Adv Drug Deliv Rev 2002; 54(2): 191-202.
[http://dx.doi.org/10.1016/S0169-409X(02)00016-9] [PMID: 11897145]
[42]
Liu D, Zhou F, Zhang J, Wang G. New insight and new methodology for herb-drug interactions based on cellular pharmacokinetics. J Nanjing Univ Trad Chinese Med 2021; 37(3): 325-30.
[43]
Chen X, Qian F, Wang Y, et al. Ginsenoside 20(S)-Rh2 promotes cellular pharmacokinetics and intracellular antibacterial activity of levofloxacin against Staphylococcus aureus through drug efflux inhibition and subcellular stabilization. Acta Pharmacol Sin 2021; 42(11): 1930-41.
[http://dx.doi.org/10.1038/s41401-021-00751-z] [PMID: 34462563]
[44]
Graf T, Heinrich K, Grunert I, et al. Recent advances in LC–MS based characterization of protein-based bio-therapeutics – mastering analytical challenges posed by the increasing format complexity. J Pharm Biomed Anal 2020; 186: 113251.
[http://dx.doi.org/10.1016/j.jpba.2020.113251] [PMID: 32251978]
[45]
Sun X, Yan X, Hao C. Confocal laser scanning microscopy, a general guideline and its applications. Shanxi Nongye Daxue Xuebao 2016; 36(1): 1-9, 14.
[46]
Kirkby M, Sabri AB, Scurr DJ, Moss GP. Dendrimer-mediated permeation enhancement of chlorhexidine digluconate: Determination of in vitro skin permeability and visualisation of dermal distribution. Eur J Pharm Biopharm 2021; 159: 77-87.
[http://dx.doi.org/10.1016/j.ejpb.2020.12.014] [PMID: 33359754]
[47]
Sans M, Gharpure K, Tibshirani R, et al. Metabolic markers and statistical prediction of serous ovarian cancer aggressiveness by ambient ionization mass spectrometry imaging. Cancer Res 2017; 77(11): 2903-13.
[http://dx.doi.org/10.1158/0008-5472.CAN-16-3044] [PMID: 28416487]
[48]
León M, Ferreira CR, Eberlin LS, et al. Metabolites and lipids associated with fetal swine anatomy via desorption electrospray ionization – mass spectrometry imaging. Sci Rep 2019; 9(1): 7247.
[http://dx.doi.org/10.1038/s41598-019-43698-2] [PMID: 31076607]
[49]
Hinners P, Thomas M, Lee YJ. Determining fingerprint age with mass spectrometry imaging via ozonolysis of triacylglycerols. Anal Chem 2020; 92(4): 3125-32.
[http://dx.doi.org/10.1021/acs.analchem.9b04765] [PMID: 31898459]
[50]
Jiang H, Gao S, Hu G, He J, Jin H. Innovation in drug toxicology: Application of mass spectrometry imaging technology. Toxicology 2021; 464: 153000.
[http://dx.doi.org/10.1016/j.tox.2021.153000] [PMID: 34695509]
[51]
Jain AK, Thareja S. in vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery. Artif Cells Nanomed Biotechnol 2019; 47(1): 524-39.
[http://dx.doi.org/10.1080/21691401.2018.1561457] [PMID: 30784319]
[52]
Donahue ND, Acar H, Wilhelm S. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Adv Drug Deliv Rev 2019; 143: 68-96.
[http://dx.doi.org/10.1016/j.addr.2019.04.008] [PMID: 31022434]
[53]
Nair AL, Mesch L, Schulz I, et al. Parallelizable microfluidic platform to model and assess in vitro cellular barriers: Technology and application to study the interaction of 3d tumor spheroids with cellular barriers. Biosensors 2021; 11(9): 314.
[http://dx.doi.org/10.3390/bios11090314] [PMID: 34562904]
[54]
Turtoi M, Anghelache M, Bucatariu SM, et al. A novel platform for drug testing: Biomimetic three-dimensional hyaluronic acid-based scaffold seeded with human hepatocarcinoma cells. Int J Biol Macromol 2021; 185: 604-19.
[http://dx.doi.org/10.1016/j.ijbiomac.2021.06.174] [PMID: 34216662]

Rights & Permissions Print Cite
Article Metrics
1
© 2024 Bentham Science Publishers | Privacy Policy